SCHEDULE 13G/A

Keenova Therapeutics PLC

Ordinary Shares, par value $0.01 per share · CUSIP: G5890A102

Event date: 2025-09-30

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares

Unavailable

Percent of class

Unavailable

• MARATHON ASSET MANAGEMENT GP, L.L.C.

  Shares: 3,030,311.00 · Class: 7.7%

• MARATHON ASSET MANAGEMENT, L.P.

  Shares: 3,030,311.00 · Class: 7.7%

• MARATHON BLUE GRASS CREDIT FUND, LP

  Shares: 319,726.00 · Class: 0.8%

• MARATHON CENTRE STREET PARTNERSHIP, L.P.

  Shares: 426,265.00 · Class: 1.1%

• MARATHON STEPSTONE MASTER FUND LP

  Shares: 78,188.00 · Class: 0.2%

• MCSP SUB LLC

  Shares: 100,764.00 · Class: 0.3%

• QUAESTIO ALTERNATIVE FUNDS S.C.A., SICAV-FIS: CMAB - SIF - CREDIT MULTI ASSET POOL B

  Shares: 1,344.00 · Class: 0.0%

• TRS CREDIT FUND, LP

  Shares: 330,188.00 · Class: 0.8%

• MDCF II INVESTMENT FUND A SCSP

  Shares: 752,102.00 · Class: 1.9%

• MARATHON DISTRESSED CREDIT FUND, L.P.

  Shares: 1,002,997.00 · Class: 2.5%

• MARATHON SPECIAL OPPORTUNITY MASTER FUND LTD

  Shares: 18,737.00 · Class: 0.1%

• BRUCE RICHARDS

  Shares: 3,030,311.00 · Class: 7.7%

• LOUIS HANOVER

  Shares: 3,030,311.00 · Class: 7.7%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.